PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.40%
Revenue growth above 1.5x MTDR's 10.25%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
81.45%
Gross profit growth above 1.5x MTDR's 49.19%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
60.76%
EBIT growth 75-90% of MTDR's 73.51%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
60.76%
Operating income growth at 75-90% of MTDR's 73.51%. Bill Ackman would demand a plan to enhance operating leverage.
59.63%
Net income growth at 75-90% of MTDR's 67.60%. Bill Ackman would press for improvements to catch or surpass competitor performance.
59.49%
EPS growth at 75-90% of MTDR's 67.65%. Bill Ackman would push for improved profitability or share repurchases to catch up.
59.66%
Diluted EPS growth at 75-90% of MTDR's 67.65%. Bill Ackman would expect further improvements in net income or share count reduction.
-0.28%
Share reduction while MTDR is at 0.08%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.28%
Dividend growth of 0.28% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
45.84%
Similar OCF growth to MTDR's 43.85%. Walter Schloss would assume comparable operations or industry factors.
164.79%
FCF growth 1.25-1.5x MTDR's 144.53%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-39.31%
Negative 10Y revenue/share CAGR while MTDR stands at 1235.29%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-3.54%
Negative 5Y CAGR while MTDR stands at 143.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-5.17%
Negative 3Y CAGR while MTDR stands at 35.45%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-55.53%
Negative 10Y OCF/share CAGR while MTDR stands at 836.86%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
4.46%
Below 50% of MTDR's 408.65%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
46.32%
3Y OCF/share CAGR at 50-75% of MTDR's 90.87%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-730.97%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
34.70%
Below 50% of MTDR's 71.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-101.34%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-87.41%
Negative equity/share CAGR over 10 years while MTDR stands at 59.58%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-59.50%
Negative 5Y equity/share growth while MTDR is at 92.36%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-57.18%
Negative 3Y equity/share growth while MTDR is at 3.19%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-90.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-59.95%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
28.73%
3Y dividend/share CAGR of 28.73% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-14.75%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-4.54%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-77.70%
We cut SG&A while MTDR invests at 9.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.